Vicki Suzanne Klimberg

University Of Arkansas Med Scis Ltl Rock

$511,200

Attributed

$511,200

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $5.7M · FY2020–25

$10M$7.5M$5M$2.5M$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$11,519,230 · 2

By mechanism

UM1$11,008,030 · 1

R21$511,200 · 1

Top collaborators

Most similar at University Of Arkansas Med Scis Ltl Rock

Same institution · by research overlap

Vladimir P Zharov$7,812,567

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchBiopsyCytokineClinical Trials NetworkCollaborationsCritical PathwaysBiologicalCancer CenterAuthorshipClinical Trials DesignAdvanced DevelopmentAdverse EventBiochemicalCommon NeoplasmClinical TrialsCancer Health DisparityCarcinogenesisCirculating BiomarkersCirculating DnaClinicClinically RelevantClinical PracticeDiagnosticDose

Grant awards (6)

Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,679,285

UM1 · FY2025 · CA

Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,679,285

UM1 · FY2024 · CA

Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,952,013

UM1 · FY2023 · CA

Texas EXperimental Cancer Therapeutics Network - TEX CTN$5,697,447

UM1 · FY2020 · CA

Percutaneous Removal &Margin Ablation for Breast Cancer$255,600

R21 · FY2004 · CA

Percutaneous Removal &Margin Ablation for Breast Cancer$255,600

R21 · FY2003 · CA